Paternity desire during rheumatic diseases under DMARDs: Information of patients and neonatal consequences in a French cohort of 156 patients

Joint Bone Spine. 2023 Jan;90(1):105458. doi: 10.1016/j.jbspin.2022.105458. Epub 2022 Sep 13.
No abstract available

Keywords: DMARD; Neonatal outcomes; Paternity; Patient information; Sulfasalazine.

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents* / adverse effects
  • Humans
  • Infant, Newborn
  • Methotrexate
  • Paternity
  • Rheumatic Diseases* / drug therapy
  • Rheumatic Diseases* / epidemiology
  • Sulfasalazine

Substances

  • Antirheumatic Agents
  • Sulfasalazine
  • Methotrexate